Call for registration
Aims:
The main aims of this workshop are:
	To allow participating laboratories to assess the sensitivity/specificity of their IAA assays, to evaluate the effect of changes in assay method, particularly in the light of the current DASP IAA training programme.
	To evaluate the effect of use of an insulin antibody standard curve in improving concordance between laboratories.
	To allow participating laboratories to assess the sensitivity/specificity of their GADA and IA-2A assays as in DASP 2002.
	To assess concordance between laboratories of GADA and IA-2A results are expressed in WHO units/ml derived from calibrated in-house standards.
	To assess reproducibility of results in a subset of patient samples included in DASP 2000 and DASP 2002.
Samples:
Participating laboratories will receive:
	150 samples from patients with newly diagnosed diabetes and non-diabetic controls. Samples will be provided in individually coded 100 ml aliquots, that cannot be combined. Assays using volumes Ž100ml are not therefore suitable for inclusion in the workshop
	Serial dilutions of serum from an insulin treated patient to be included in each IAA assay
	WHO standard reagent for GADA and IA-2A with negative diluent to allow calibration of in house standards in WHO units/ml if the laboratory has not already completed this exercise in DASP 2002
	An Excel worksheet
Registration fees
	Normal participation (non-profit making institutions) US $150 Participants who have submitted patient sera within the last 2 years Free Commercial participants US $1000
Deadlines
	Registration deadline June 30th 2003
	Return of results September 30th 2003
	Presentation of results IDS meeting April 2004
	Download your registration form here